Dergiler / Üroonkoloji Bülteni / 2020 / Cilt: 19 - Sayı: 1

The Role of Adrenal Cortex-Sparing Surgery for Bilateral Masses in Three Cases

Sayfa
42–46
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, cortex-sparing surgery may be a good alternative to total adrenalectomy for the patients with small benign functional adrenal tumors or bilateral genetic pheochromocytoma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pheochromocytoma are the functional adrenal lesions originating from the chromaffin cells.
📊
Temel Bulgular & Veri:For the cases of pheochromocytoma observed in multiple endocrine neoplasia Type 2 and Von Hippel syndrome, the bilateral adrenal glands are involved.
💡
Sonuç & Katkı:Therefore, cortex-sparing surgery may be a good alternative to total adrenalectomy for the patients with small benign functional adrenal tumors or bilateral genetic pheochromocytoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Pheochromocytoma are the functional adrenal lesions originating from the chromaffin cells. For the cases of pheochromocytoma observed in multiple endocrine neoplasia Type 2 and Von Hippel syndrome, the bilateral adrenal glands are involved. In classical approach, total adrenalectomy is applicable on such masses while adrenal failure is almost inevitable. Lifelong cortisol and fludrocortisones replacement are necessary for the patients with adrenal failure while the rate of morbidity and mortality has significantly increased. With the introduction of the minimal invasive surgical approach, cortex sparing adrenalectomy has been brought forward for the adrenal tumors. The primary objective of the cortex sparing surgery is to prevent the lifelong replacement and the permanent adrenal failure after adrenalectomy. Therefore, it is particularly preferred in the case of genetic pheochromocytoma with bilateral adrenal involvement. However, in the case of the selected cases, it can also be applicable for adenoma producing aldostrerone and Cushing syndrome. The adrenal tumor will be completely removed and if sufficient tissue is reserved in the manner to preserve the cortex function, no long-term recurrence and adrenal failure is to be developed. Therefore, cortex-sparing surgery may be a good alternative to total adrenalectomy for the patients with small benign functional adrenal tumors or bilateral genetic pheochromocytoma.

🔖

Bu Makaleye Atıf Yap

KAN, E. K., ÖZDEN, E., ATMACA, A., ÇOLAK, R. (2020). The Role of Adrenal Cortex-Sparing Surgery for Bilateral Masses in Three Cases. Üroonkoloji Bülteni, Cilt: 19 - Sayı: 1, 42–46. https://ajindex.com/articles/334430

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Husebye ES, Allolio B, Arlt W, et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014;275:104-115
  2. Madala A, Daugherty M, Bratslavsky G. Partial Adrenalectomy. Why Should it be Considered? Urology Practice 2015;2:359-366
  3. Walz MK. Extent of adrenalectomy for adrenal neoplasm: cortical sparing (subtotal) versus total adrenalectomy. Surg Clin N Am 2004;84:743-753
  4. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 1992;327:1033
  5. Conzo G, Tartaglia E, Gambardella C, et al. Minimally invasive approach for adrenal lesions: Systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complications. Int J Surg 2016;28:118-123
  6. Castinetti F, Qi XP, Walz MK, et al. Outcomes of adrenal- sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 2014;15:648-655
  7. Lee JE, Curley SA, Gagel RF, et al. Cortical sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 1996;120:1064-1071
  8. Kaye DR, Storey BB, Pacak K, et al. Partial adrenalectomy underused first line therapy for small adrenal tumors. J Urol 2010;184:18-25
  9. Vidal O, Delgado-Oliver E, Diaz del Gabbo R, et al. Functional Adrenal Cortex Preservation: A Good Reason for Posterior Retroperitoneal Endoscopic Approach. Cır Esp 2018;96:488-493
  10. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 2003;361:2059-2067
  11. Inabnet WB, Caragliano P, Pertsemlidis D. Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery 2000;128:1007-1011
  12. Fu B, Zhang X, Wang G, et al. Long-Term Results of a Prospective, Randomized Trial Comparing Retroperitoneoscopic Partial Versus Total Adrenalectomy for Aldosterone Producing Adenoma. The J Urol 2011;185:1578-1582
  13. He HC, Dai J, Shen Z, et al. Retroperitoneal Adrenal-Sparing Surgery for the Treatment of Cushing’s Syndrome Caused by Adrenocortical Adenoma:8-Year Experience With 87 Patients. World J Surg 2012;36:1182-1188
  14. Walz MK, Peitgen K, Diesing D, et al. Partial versus Total Adrenalectomy by the Posterior Retroperitoneoscopic Approach: Early and Longterm Results of 325 Consecutive Procedures in Primary Adrenal Neoplasia. World J Surg 2004;28:1323-1329